Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 10, 2002, Pages 1441-1446

  Reybrouck, Tony ^a   Heidbüchel, Hein ^a   Van De Werf, Frans ^a   Ector, Hugo ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cardioinhibitory syncope; Orthostatic intolerance; Syncope; Tilt table testing; Vasodepressor syncope

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BELGIUM; CHILD; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT COMPLIANCE; RECURRENT DISEASE; SYNCOPE; TILT TABLE TEST;

EID: 0036801643     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01441.x     Document Type: Article

References (27)

1. Grubb BP. Pathophysiology and differential diagnosis of neurocardiogenic syncope. Am J Cardiol 1999; 84: 3Q-9Q.
2. Sutton R, Petersen M, Brignole M, et al. Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992; 2: 180-183.
3. Ector H. Neurocardiogenic, vasovagal syncope. Eur Heart J 1999; 20: 1686-1687.
4. Sutton R, Brignole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicenter randomized study. Circulation 2000; 102: 294-299.
5. Santini M, Ammirati F, Colivicchi F, et al. The effect of atropine in vasovagal syncope induced by head-up tilt testing. Eur Heart J 1999; 20: 1745-1751.
6. Atiga WL, Rowe P, Calkins P Management of vasovagal syncope. J Cardiovasc Electrophysiol 1999; 10: 874-876.
7. Benditt DG, Fahy GJ, Lurie KG, et al. Pharmacotherapy of neurally mediated syncope. Circulation 1999; 100: 1242-1248.
8. Ector H, Reybrouck T, Heidbüchel H, et al. Tilt training: A new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. PACE 1998; 21: 193-196.
9. Reybrouck T, Heidbüchel H, Van De Werf F, et al. Tilt training: A treatment for malignant and recurrent neurocardiogenic syncope. PACE 2000; 23: 493-498.
10. Brignole M, Alboni P, Benditt D, et al. Task Force on Syncope: Guidelines on Management (diagnosis and treatment of syncope). Eur Heart J 2001; 22: 1256-1306.
11. Sutton R, Petersen MEV. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 1995; 6: 595-576.
12. Di Girolamo E, Di Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. A controlled study, Circulation 1999; 100: 1798-2001.
13. Numata T, Abe H, Nagatomo T, et al. Successful treatment of malignant neurocardiogenic syncope with repeated tilt training program. Jpn Circ J 2000; 64: 406-409.
14. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine 1990; 69: 160-175.
15. Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70: 339-342.
16. Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16-20.
17. Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia 1998; 43: 833-837.
18. Pavy-Le Traon A, Sigaudo D, Vasseur P, et al. Cardiovascular responses to orthostatic tests after 42-day head-down bed rest. Eur J Appl Physiol 1998; 77: 50-59.
19. Greenleaf JE, Wade CE, Leftheriothis G. Orthostatic responses following 30-day bed rest deconditioning with isotonic and isokinetic exercise training. Aviat Space Environ Med 1989; 60: 537-542.
20. Convartino V. Conditions of reduced gravidity. In PA Low (ed.): Clinical Autonomic Disorders. Philadelphia, Lippincott Raven, 1997, pp. 429-440.
21. Guell A, Braak L, Pavy-Le Traon A, et al. Cardiovascular adaptation during simulated microgravidity: Lower body negative pressure to counter orthostatic hypotension. Aviat Space Environ Med 1991; 62: 331-335.
22. Arbeille P, Gauquelin G, Pottier JM, et al. Results of a 4-week head-down tilt with and without LBPN countermeasure: II Cardiac and peripheral hemodynamics-comparison with a 25-day spaceflight. Aviat Space Environm Med 1992; 63: 9-13.
23. Morillo CA. Leitch JW, Yee R, et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993; 22: 1843-1848.
24. Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt test in patients with syncope. Circulation 1996; 93: 973: 981.
25. Benditt DG. Cardiac pacing for prevention of vasovagal syncope. Am Coll Cardiol 1999; 33: 21-23.
26. Grubb BP, Kosinsky D. Tilt table testing: Concepts and limitations. PACE 1997; 20: 781-787.
27. Benditt DG. Neurally mediated syncopal syndromes: Pathophysiological concepts and clinical evaluation. (editorial) PACE 1999; 20: 572-584.